
Inaayadepa M 10mg/500mg Tablet ER
Marketer
Inaaya Healthtech Pvt Ltd
Salt Composition
Dapagliflozin (10mg) + Metformin (500mg)
Overview Inaayadepa M 10mg/500mg Tablet ER
Metformin/glimepiride extended-release tablets (10mg/500mg) are a dual-action medication for managing type 2 diabetes. They work by regulating elevated blood glucose, thus mitigating the risk of severe diabetic complications and cardiovascular issues. This medication can be taken with food and should be consumed at the same time daily for consistent blood sugar control. Dosage is determined by your physician; discontinuation should only occur under their supervision, as abrupt cessation may lead to dangerously high blood sugar levels and potentially serious consequences such as renal impairment or vision loss. This medication forms part of a comprehensive treatment plan that necessitates a healthy diet, regular physical activity, and weight management as directed by your doctor. Frequently reported side effects include throat irritation, nasal stuffiness, rhinorrhea, cephalalgia, nausea, emesis, and diarrhea. Adequate hydration is crucial to minimize dehydration. Genital fungal infections are a possibility; meticulous hygiene can reduce this risk. Prior to commencing treatment, disclose any renal or hepatic dysfunction, urinary tract infections, or diuretic use to your doctor. Pregnant or lactating individuals should seek medical counsel before use. Limit alcohol consumption as it may intensify adverse effects. Regular blood glucose monitoring is essential during treatment.
Primary Ingredients of Inaayadepa M 10mg/500mg Tablet ER
No text provided to rephrase.
Uses of Inaayadepa M 10mg/500mg Tablet ER
Managing type 2 diabetes
Major Benefits of Inaayadepa M 10mg/500mg Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Inaayadepa M 10mg/500mg Extended-Release tablet whole; do not chew, crush, or divide it. Administer this medicine with food.
Common Side effects of Inaayadepa M 10mg/500mg Tablet ER:
- Nausea
- Vomiting
- Diarrhea
- Genital fungal infection
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Urinary tract infection
- Polyuria
- Flatulence
- Skin rash
- Taste change
- Difficulty in urination
- Hypoglycemia (low blood glucose level)
- Tremors
- Dizziness
- Back pain
- Increased hematocrit
- Decreased creatinine clearance
- Dyslipidemia
How to use Inaayadepa M 10mg/500mg Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Inaayadepa M 10mg/500mg Extended-Release tablet whole; do not crush, chew, or break it. Administer this medication with food.
How Inaayadepa M 10mg/500mg Tablet ER works:
Inaayadepa M extended-release tablets (10mg/500mg) combine dapagliflozin and metformin to manage type 2 diabetes. Dapagliflozin eliminates excess glucose via urinary excretion, while metformin reduces hepatic glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. This dual action improves glycemic control.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol use with Inaayadepa M 10mg/500mg extended-release tablets is contraindicated.
PregnancyCONSULT YOUR DOCTOR
The extended-release Inaayadepa M 10mg/500mg tablet might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Inaayadepa M 10mg/500mg tablets may pose a risk to breastfeeding infants. Available evidence indicates potential transfer to breast milk with possible infant harm.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Inaayadepa M 10mg/500mg Extended-Release tablets. Dosage modification of Inaayadepa M 10mg/500mg Extended-Release tablets may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with liver impairment should use Inaayadepa M 10mg/500mg Extended-Release tablets cautiously. Dosage modification of Inaayadepa M 10mg/500mg Extended-Release tablets may be necessary; physician consultation is advised.
What if you forget to take Inaayadepa M 10mg/500mg Tablet ER :
Should you forget to take your Inaayadepa M 10mg/500mg Extended-Release Tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication timetable. Avoid taking a double dose.
Facts to Know About Inaayadepa M 10mg/500mg Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
